Work

A decade of patient-focused innovation in the delivery of apomorphine infusion to improve the treatment experience for people with Parkinson’s

Year: 2026

Type: article

Source: Parkinsonism & Related Disorders

DOI: 10.1016/j.parkreldis.2026.108782

Authors: B. Amlani, V. Correa-Gallego

Institution: Britannia Pharmaceuticals Ltd (United Kingdom)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7225147170

FWCI:

Cites:

Cited by:

Related to: 10